These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20183956)

  • 61. Statin Use in Very Elderly Individuals, 1999-2012.
    Johansen ME; Green LA
    JAMA Intern Med; 2015 Oct; 175(10):1715-6. PubMed ID: 26301475
    [No Abstract]   [Full Text] [Related]  

  • 62. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The use of cardiovascular risk factor information in practice databases.
    Holt T; Thorogood M; Griffiths F
    Br J Gen Pract; 2006 Nov; 56(532):883-4. PubMed ID: 17132357
    [No Abstract]   [Full Text] [Related]  

  • 64. [Primary prevention and screening in adults: update 2014].
    Cornuz J; Jacot-Sadowski I; Nanchen D; Auer R; Senn N; Lazor R; Guessous I
    Rev Med Suisse; 2014 Jan; 10(414):177-8, 180-5. PubMed ID: 24624735
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
    Naderi SH; Bestwick JP; Wald DS
    Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions.
    Hennekens CH; Dalen JE
    Am J Med; 2013 May; 126(5):373-8. PubMed ID: 23499330
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Accreditation of clinical centres providing primary prevention, secondary prevention and rehabilitation, and sports cardiology: A step towards optimizing quality.
    Janssen A; Wagenaar KP; Dendale P; Grobbee DE
    Eur J Prev Cardiol; 2019 Nov; 26(16):1775-1777. PubMed ID: 31362532
    [No Abstract]   [Full Text] [Related]  

  • 68. Imaging for prevention.
    Shaw LJ
    Med Clin North Am; 2012 Jan; 96(1):103-12. PubMed ID: 22391255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Exercise prescription and primary prevention of cardiovascular disease.
    Metkus TS; Baughman KL; Thompson PD
    Circulation; 2010 Jun; 121(23):2601-4. PubMed ID: 20547940
    [No Abstract]   [Full Text] [Related]  

  • 70. Validity of a long-term cardiovascular disease risk prediction equation for low-incidence populations: the CAMUNI-MATISS Cohorts Collaboration study.
    Veronesi G; Gianfagna F; Giampaoli S; Chambless LE; Grassi G; Cesana G; Ferrario MM
    Eur J Prev Cardiol; 2015 Dec; 22(12):1618-25. PubMed ID: 25501263
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Polish forum for prevention guidelines on cardiovascular risk assessment].
    Podolec P; Kopeć G; Pajak A; Undas A; Kozek E; Tykarski A; Naruszewicz M; Stańczyk J; Opala G; Godycki-Cwirko M; Rynkiewicz A; Torbicki A; Musiał J
    Kardiol Pol; 2007 Jan; 65(1):100-4. PubMed ID: 17295170
    [No Abstract]   [Full Text] [Related]  

  • 72. The cardiovascular polypill in high-risk patients.
    Lafeber M; Spiering W; Singh K; Guggilla RK; Patil V; Webster R;
    Eur J Prev Cardiol; 2012 Dec; 19(6):1234-42. PubMed ID: 22019908
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Thromboembolism--risk, prevention and therapy. Practice Guideline].
    ;
    Orv Hetil; 2009 Dec; 150(52):2335-404. PubMed ID: 20031519
    [No Abstract]   [Full Text] [Related]  

  • 74. The Polypill: From Promise to Pragmatism.
    Huffman MD
    PLoS Med; 2015 Aug; 12(8):e1001862. PubMed ID: 26263422
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Concurrent Validity of the Historical Leisure-time Physical Activity Question of the Spanish National Health Survey in Older Adults.
    Martínez-Gómez D; Guallar-Castillón P; Higueras-Fresnillo S; Rodríguez-Artalejo F
    Rev Esp Cardiol (Engl Ed); 2017 Aug; 70(8):669-670. PubMed ID: 27789171
    [No Abstract]   [Full Text] [Related]  

  • 76. The editor's roundtable: effect of nonsteroidal anti-inflammatory drugs on blood pressure.
    Friedewald VE; Ram CV; Wesson DE; White WB; Williams GW; Roberts WC
    Am J Cardiol; 2010 Jun; 105(12):1759-67. PubMed ID: 20538127
    [No Abstract]   [Full Text] [Related]  

  • 77. Best practice for prevention and treatment of cardiovascular disease through an equity lens: a review.
    Beauchamp A; Peeters A; Tonkin A; Turrell G
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):599-606. PubMed ID: 20562629
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiovascular prevention: components, levels, early origins, and metrics.
    Kones R; Rumana U
    Hosp Pract (1995); 2014 Aug; 42(3):84-95. PubMed ID: 25255410
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders.
    Cohen AT; Imfeld S; Markham J; Granziera S
    Thromb Res; 2015 Feb; 135(2):217-25. PubMed ID: 25541030
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gender-specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention.
    Lombardi M; Mercuro G; Fini M; Rosano GM
    Fundam Clin Pharmacol; 2010 Dec; 24(6):699-705. PubMed ID: 20584207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.